These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 21706927

  • 21. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C, Simon F, Dordain ML.
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract] [Full Text] [Related]

  • 22. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ, Aminjavaheri M.
    Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
    [Abstract] [Full Text] [Related]

  • 23. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil.
    Romero GA, Molinet FJ, Noronha EF.
    Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):266-8. PubMed ID: 23315614
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
    Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verástegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A.
    J Infect Dis; 2007 Jun 15; 195(12):1846-51. PubMed ID: 17492601
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases.
    Sadeghian G, Ziaei H, Shirani-Bidabadi L, Nilforoushzadeh MA.
    East Mediterr Health J; 2010 Mar 15; 16(3):344-5. PubMed ID: 20795453
    [No Abstract] [Full Text] [Related]

  • 29. Alterations in phenotypic profiles of peripheral blood cells from patients with human American cutaneous leishmaniasis following treatment with an antimonial drug and a vaccine.
    Botelho AC, Mayrink W, Oliveira RC.
    Acta Trop; 2009 Nov 15; 112(2):143-8. PubMed ID: 19631187
    [Abstract] [Full Text] [Related]

  • 30. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
    Alborzi A, Pouladfar GR, Fakhar M, Motazedian MH, Hatam GR, Kadivar MR.
    Am J Trop Med Hyg; 2008 Sep 15; 79(3):435-7. PubMed ID: 18784238
    [Abstract] [Full Text] [Related]

  • 31. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
    Nilforoushzadeh MA, Shirani-Bidabadi L, Zolfaghari-Baghbaderani A, Saberi S, Siadat AH, Mahmoudi M.
    J Vector Borne Dis; 2008 Dec 15; 45(4):301-6. PubMed ID: 19248657
    [Abstract] [Full Text] [Related]

  • 32. Miltefosine in cutaneous leishmaniasis.
    Rahman SB, ul Bari A, Mumtaz N.
    J Coll Physicians Surg Pak; 2007 Mar 15; 17(3):132-5. PubMed ID: 17374296
    [Abstract] [Full Text] [Related]

  • 33. Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy.
    Lobo IM, Soares MB, Correia TM, de Freitas LA, Oliveira MI, Nakatani M, Netto E, Badaro R, David JR.
    Trans R Soc Trop Med Hyg; 2006 Jul 15; 100(7):642-9. PubMed ID: 16274713
    [Abstract] [Full Text] [Related]

  • 34. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG.
    J Infect Dis; 2006 May 15; 193(10):1375-83. PubMed ID: 16619185
    [Abstract] [Full Text] [Related]

  • 35. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I, Alavi A.
    Int J Dermatol; 2002 Aug 15; 41(8):521-4. PubMed ID: 12207774
    [Abstract] [Full Text] [Related]

  • 36. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B, Abbaszadeh B, Khamesipour A.
    Eur J Dermatol; 2005 Aug 15; 15(2):85-7. PubMed ID: 15757817
    [Abstract] [Full Text] [Related]

  • 37. Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial.
    Dastgheib L, Naseri M, Mirashe Z.
    Int J Dermatol; 2012 Dec 15; 51(12):1508-11. PubMed ID: 23171020
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis.
    Kashani MN, Firooz A, Eskandari SE, Ghoorchi MH, Khamesipour A, Khatami A, Javadi A, Dowlati Y.
    Eur J Dermatol; 2007 Dec 15; 17(6):513-5. PubMed ID: 17951131
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis.
    Asilian A, Sharif A, Faghihi G, Enshaeieh Sh, Shariati F, Siadat AH.
    Int J Dermatol; 2004 Oct 15; 43(10):736-8. PubMed ID: 15485530
    [Abstract] [Full Text] [Related]

  • 40. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S, Javadi A, Dabiri S, Shamsi Meymandi M, Nadji M.
    Arch Iran Med; 2011 Jul 15; 14(4):238-43. PubMed ID: 21726098
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.